Figures & data
Table 1. Demographic and clinical characteristics of the subjects.
Figure 1. Levels of IL-32 (pg/ml) in BALF and IS from patients with COPD patients, asthma and healthy subjects. Data are shown as median (range). *P < 0.05, compared with patients with asthma #P < 0.05, compared with healthy subjects.
![Figure 1. Levels of IL-32 (pg/ml) in BALF and IS from patients with COPD patients, asthma and healthy subjects. Data are shown as median (range). *P < 0.05, compared with patients with asthma #P < 0.05, compared with healthy subjects.](/cms/asset/933fae39-2135-45ff-965e-2e664d70c912/icop_a_1145201_f0001_b.gif)
Table 2. Distribution of IL-32 concentration according to the smoking status.
Figure 2. Association between BAL fluid IL-32 levels and number of macrophages in patients with COPD (A) and asthma (B).
![Figure 2. Association between BAL fluid IL-32 levels and number of macrophages in patients with COPD (A) and asthma (B).](/cms/asset/722b5c32-07b0-4e07-b9c5-842345749d38/icop_a_1145201_f0002_b.gif)
Table 3. Differential cell counts in IS supernatant and BAL fluid.